Back to News
Market Impact: 0.25
IMUNON To Sell ThermoDox Rights To VoxelDox For Glioblastoma Multiforme
Source: Nasdaq
Healthcare & BiotechM&A & RestructuringCompany Fundamentals
IMUNON agreed to sell its rights to ThermoDox to VoxelDox Therapeutics in exchange for an equity stake, potential milestone payments and royalties. The announcement does not disclose the stake size or payment amounts.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
IMNN0.45
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Elon Musk Thinks $3.5 Trillion Tesla-SpaceX Mashup Is a Good Idea
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal
- Why is Tesla stock falling after-hours today?